Latest Articles

  • Emphysematous cystitis
    Waiel Abusnina, MD, Mena Shehata, MD, Sammy Nassri, MD and Fuad Zeid, MD
    Cleveland Clinic Journal of Medicine January 2019, 86 (1) 10-11; DOI: https://doi.org/10.3949/ccjm.86a.18063

    The patient had fallen in her home and remained on the floor for 2 days until neighbors heard her cries and called 911.

  • Rapidly progressive pleural effusion
    Zaid Zoumot, MBBS, Ali S. Wahla, MBBS and Samar Farha, MD
    Cleveland Clinic Journal of Medicine January 2019, 86 (1) 21-27; DOI: https://doi.org/10.3949/ccjm.86a.18067

    A 33-year-old nonsmoker presents with severe pleuritic chest pain; the differential diagnosis is broad.

  • Common benign breast concerns for the primary care physician
    Christine Lara Klassen, MD, Stephanie L. Hines, MD and Karthik Ghosh, MD
    Cleveland Clinic Journal of Medicine January 2019, 86 (1) 57-65; DOI: https://doi.org/10.3949/ccjm.86a.17100

    Because breast cancer is so common, women with breast problems often fear the worst. They needn’t.

  • Monoclonal gammopathy of undetermined significance: A primary care guide
    Monoclonal gammopathy of undetermined significance: A primary care guide
    Jack Khouri, MD, Christy Samaras, DO, Jason Valent, MD, Alex Mejia Garcia, MD, Beth Faiman, PhD, CNP, Saveta Mathur, CNP, Kim Hamilton, CNP, Megan Nakashima, MD and Matt Kalaycio, MD
    Cleveland Clinic Journal of Medicine January 2019, 86 (1) 39-46; DOI: https://doi.org/10.3949/ccjm.86a.17133

    Low-risk MGUS may not require subspecialty referral and can be followed by the outpatient provider.

  • Acute-onset quadriplegia with hyperreflexia
    Nasreen Shaikh, MD, Muhammad Sardar, MD, Wahab Khan, MD and Wael Ghali, MD
    Cleveland Clinic Journal of Medicine January 2019, 86 (1) 7-8; DOI: https://doi.org/10.3949/ccjm.86a.18049

    MRI showed diffuse T2 hyperintensity beginning at the level of the medulla and extending to the level of C7.

  • Should metformin be used in every patient with type 2 diabetes?
    Vinni Makin, MBBS, MD, FACE and M. Cecilia Lansang, MD, MPH
    Cleveland Clinic Journal of Medicine January 2019, 86 (1) 17-20; DOI: https://doi.org/10.3949/ccjm.86a.18039

    Most patients should receive it, with exceptions. Nevertheless, it is underused.

  • A new reason to reconsider that antibiotic prescription: The microbiome
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 906-907; DOI: https://doi.org/10.3949/ccjm.85b.12018

    Prescribing an antibiotic is a far more complicated and long-lasting affair than most of us thought.

  • What can I do when first-line measures are not enough for vasovagal syncope?
    Erika Hutt-Centeno, MD and Kenneth A. Mayuga, MD, FHRS, FACC, FACP
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 920-922; DOI: https://doi.org/10.3949/ccjm.85a.17112

    Second-line measures include midodrine, fludrocortisone, beta-blockers, and SSRIs, but evidence is limited.

  • Telemedicine: Past, present, and future
    Jamal H. Mahar, MD, Gregory J. Rosencrance, MD and Peter A. Rasmussen, MD
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 938-942; DOI: https://doi.org/10.3949/ccjm.85a.17062

    Low reimbursement, licensing, practice issues limit its use.

  • Beta-cell therapies for type 1 diabetes: Transplants and bionics
    Beta-cell therapies for type 1 diabetes: Transplants and bionics
    Kathryn Bux Rodeman, MD and Betul Hatipoglu, MD
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 931-937; DOI: https://doi.org/10.3949/ccjm.85a.17088

    Chief among the challenges: millions of people have diabetes.

Pages